The main department of described VC is located in the Kita. The company was established in Asia in Japan.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2019. The fund is generally included in 2-6 deals every year.
We can highlight the next thriving fund investment areas, such as CRM, SaaS. For fund there is a match between the location of its establishment and the land of its numerous investments - Japan. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Hacarus, Hachimenroppi, Moneytree.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Senshu Ikeda Capital, startups are often financed by Salesforce Ventures, Mizuho Capital, Draper Nexus Ventures. The meaningful sponsors for the fund in investment in the same round are SMBC Venture Capital, SBI Investment, Globis Capital Partners. In the next rounds fund is usually obtained by UTEC- University of Tokyo Edge Capital, SunBridge, Salesforce Ventures.
Related Funds
Fund Name | Location |
Allen Angel Capital Education Program (AACE) | Columbia, Missouri, United States |
Bank of Nanjing | China, Jiangsu, Nanjing |
Common Angels Fund | - |
Ding Xiang Capital | Chengdu, China, Sichuan |
Duofangbu Touzi | China, Shanghai |
Guangzhou Niugaga Information Technology | China, Guangdong, Guangzhou |
Intertrust | California, Sunnyvale, United States |
Linden Capital Partners | Chicago, Illinois, United States |
Venture Capital Trust | - |
Xiamen Jinyuan Venture Capital | China, Fujian, Xiamen |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Rege Nephro | 07 Oct 2024 | Kyoto, Kyoto Prefecture, Japan | |||
SAgri | $9M | 08 Aug 2024 | Japan, Kyoto Prefecture, Japan | ||
SAgri | $1M | 05 Jun 2021 | Japan, Kyoto Prefecture, Japan | ||
On The Slope | 14 May 2021 | Kyoto, Kyoto Prefecture, Japan | |||
Luxna Biotech | $5M | 10 Feb 2020 | Osaka, Osaka Prefecture, Japan | ||
Architek | $4M | 22 Jan 2020 | Osaka, Osaka Prefecture, Japan | ||
Study Plus | $6M | 20 Jan 2020 | Kawasaki, Kanagawa Prefecture, Japan | ||
Andpad | $21M | 29 Aug 2019 | Chiyoda, Japan | ||
RT Corporation | $3M | 23 Aug 2019 | Chiyoda, Japan |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Rege Nephro | 07 Oct 2024 | Kyoto, Kyoto Prefecture, Japan | |||
SAgri | $9M | 08 Aug 2024 | Japan, Kyoto Prefecture, Japan | ||
SAgri | $1M | 05 Jun 2021 | Japan, Kyoto Prefecture, Japan | ||
On The Slope | 14 May 2021 | Kyoto, Kyoto Prefecture, Japan | |||
Luxna Biotech | $5M | 10 Feb 2020 | Osaka, Osaka Prefecture, Japan | ||
Architek | $4M | 22 Jan 2020 | Osaka, Osaka Prefecture, Japan | ||
Study Plus | $6M | 20 Jan 2020 | Kawasaki, Kanagawa Prefecture, Japan | ||
Andpad | $21M | 29 Aug 2019 | Chiyoda, Japan | ||
RT Corporation | $3M | 23 Aug 2019 | Chiyoda, Japan |